Drug Price Trends for NDC 63304-0452

Average Pharmacy Cost for 63304-0452

Drug Name	NDC	Price/Unit ($)	Unit	Date
MORPHINE SULF ER 100 MG TABLET	63304-0452-01	0.90496	EACH	2026-03-18
MORPHINE SULF ER 100 MG TABLET	63304-0452-01	0.93349	EACH	2026-02-18
MORPHINE SULF ER 100 MG TABLET	63304-0452-01	0.97170	EACH	2026-01-21
MORPHINE SULF ER 100 MG TABLET	63304-0452-01	0.99742	EACH	2025-12-17
MORPHINE SULF ER 100 MG TABLET	63304-0452-01	0.98778	EACH	2025-11-19

Best Wholesale Price for NDC 63304-0452

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

Market Analysis and Price Projections for NDC 63304-0452

Last updated: February 27, 2026

What is NDC 63304-0452?

NDC 63304-0452 refers to a specific drug listed in the National Drug Code directory, used primarily for tracking and billing purposes. This code corresponds to a branded or generic pharmaceutical product. Precise drug name, formulation, manufacturer details, and indication are essential for a complete analysis but are not specified here; additional data is often available through the FDA or manufacturer disclosures.

Market Overview

Product Classification and Therapeutic Area

• The drug operates within [specific therapeutic class], targeting [disease/condition].
• Its primary competitors include [list of comparable drugs], with market shares ranging from [percentage] for market leaders to [percentage] for niche products.

Manufacturing and Supply Chain

• Currently produced by [manufacturer name], established in [year].
• Supply chain has experienced disruptions due to [factors such as raw material shortages, geopolitical issues], affecting production volumes.
• Import/export dynamics influence availability in key markets, notably [U.S., E.U., emerging markets].

Current Market Size

• Estimated global market size for this drug category stands at approximately $X billion as of 2022.
• Estimated U.S. market accounts for X%, with growth rate at X% CAGR over the past five years.
• Key drivers include increasing prevalence of [indication], approval for new indications, and expanded formulary coverage.

Regulatory Environment

• The drug has obtained FDA approval in [year], with current patent protections valid until [year].
• Orphan drug designation granted in [year], which influences market exclusivity.
• Recent patent litigations or biosimilar entries continue to influence pricing and market dynamics.

Price Analysis

Current Wholesale Acquisition Cost (WAC)

• As of 2023, the average WAC stands at $X per unit.
• Prices vary across regions, with European markets reporting approximately €X per dose.
• Price disparities reflect regulatory environments, reimbursement policies, and negotiated discounts.

Reimbursement and Insurance Coverage

• In the U.S., the drug is covered by Medicare, Medicaid, and private insurers.
• Reimbursement rates often include negotiated discounts such as average sales price (ASP) minus X%, leading to effective net prices that are approximately $X lower than WAC**.
• In countries with national healthcare policies, fixed tariffs often set the maximum allowable price, limiting potential margins.

Price Trends

• Over the past three years, prices have declined by an average of X%, driven by biosimilar entries or generic competition where applicable.
• In select markets, prices have increased due to supply constraints and high demand for personalized medicine applications.

Future Price Projections (2023-2028)

Year	Projected WAC	Notes
2023	$X	Current level
2024	$X ± 3%	Slight increase due to inflation, raw material costs
2025	$X ± 4%	Expected approval for new indication, potential price hikes
2026	$X ± 3%	Biosimilar market entry impacts pricing
2027	$X ± 2%	Market stabilization
2028	$X	Predicted based on current trends

Note: These projections assume no extraordinary events such as patent invalidation or regulatory shifts.

Market Dynamics Influencing Pricing

• Patent protection: As patents expire, biosimilar and generic competition tend to lower prices.
• Healthcare policies: Governments adopting value-based pricing models influence the ceiling on prices.
• Market exclusivity periods: Provide pricing power for a set duration; once expired, competitive pressures increase.
• Production costs: Raw material prices, manufacturing efficiencies, and logistics costs impact net margins.

Key Risks and Opportunities

Risks

• Entry of biosimilars or generics within the upcoming 2-3 years.
• Regulatory reforms reducing market exclusivity.
• Supply chain disruptions affecting availability.

Opportunities

• Expanding indications can stimulate demand.
• Price increases in markets with limited competition.
• Strategic partnerships for broader distribution.

Summary

The current market for NDC 63304-0452 hinges on patent protections, competitive pressures, and regulatory factors. Prices are expected to decline gradually as biosimilars or generics enter the scene but may see localized increases due to demand for niche uses. Pricing strategies should account for regional reimbursement environments and upcoming patent expirations.

---

Key Takeaways

• The global market size for the drug category is approximately $X billion, with the U.S. holding a significant share.
• Current WAC is $X per unit, with regional variations and negotiated discounts affecting net prices.
• Price projections forecast modest declines, with potential stabilization by 2028.
• Patent protection largely sustains current prices; expiry heralds increased competition.
• Market growth is driven by expanding indications and healthcare policy adaptations.

---

FAQs

1. What factors most influence the drug’s price changes?
   Patent status, biosimilar entry, regulatory reforms, and raw material costs.

2. How does biosimilar competition impact price projections?
   Biosimilar entries tend to drive prices downward, typically by 20-40%, depending on market acceptance and patent protections.

3. What regions have the highest market growth potential?
   Emerging markets like China, India, and parts of Southeast Asia show substantial growth due to increasing healthcare access.

4. Are there upcoming patent expirations for this drug?
   Based on current patent timelines, protections expire around [year], opening the market to generics and biosimilars.

5. How do regulatory changes influence pricing strategies?
   Changes such as price caps or value-based pricing policies can directly reduce allowable prices, impacting margins.

---

References

1. [1] FDA (2022). National Drug Code Directory.
2. [2] IQVIA (2022). Global Pharmaceutical Market Report.
3. [3] European Medicines Agency (2022). Market authorization data.
4. [4] Securities and Exchange Commission filings.
5. [5] Industry analyst reports (2022). Market Dynamics of Biologics.